Quentin Van Thillo Selected Research

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)

1/2021

Oncogenic cooperation between TCF7-SPI1 and NRAS(G12D) requires β-catenin activity to drive T-cell acute lymphoblastic leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Quentin Van Thillo Research Topics

Disease

2	COVID-19 10/2022 - 01/2022
1	Neoplasms (Cancer) 01/2023
1	Hypereosinophilic Syndrome (Loeffler Endocarditis) 01/2023
1	T-Cell Lymphoma (Lymphoma, T Cell) 12/2022
1	Thromboinflammation 10/2022
1	Leukemia 01/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2021

Drug/Important Bio-Agent (IBA)

1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 01/2023
1	Histone Deacetylase InhibitorsIBA 12/2022
1	Histone Deacetylases (Histone Deacetylase)IBA 12/2022
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 10/2022
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 10/2022
1	Aprotinin (Trasylol)FDA Link 10/2022
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2022
1	lambda Spi-1IBA 01/2021
1	CateninsIBA 01/2021